Do gabapentin or pregabalin directly modulate the µ receptor?
Background Pregabalin and gabapentin improve neuropathic pain symptoms but there are emerging concerns regarding their misuse. This is more pronounced among patients with substance use disorder, particularly involving opioids. Co-ingestion of gabapentinoids with opioids is increasingly identified in...
Huvudupphovsmän: | Preeti Manandhar, Bridin Patricia Murnion, Natasha L. Grimsey, Mark Connor, Marina Santiago |
---|---|
Materialtyp: | Artikel |
Språk: | English |
Publicerad: |
PeerJ Inc.
2021-04-01
|
Serie: | PeerJ |
Ämnen: | |
Länkar: | https://peerj.com/articles/11175.pdf |
Liknande verk
Liknande verk
-
Gabapentin and pregabalin exposures reported to United States poison centers, 2012–2022
av: Emily J.R. Carter, et al.
Publicerad: (2024-11-01) -
A Systematic Review of the Clinical Use of Gabapentin and Pregabalin in Bipolar Disorder
av: Qin Xiang Ng, et al.
Publicerad: (2021-08-01) -
Efficacy and safety of pregabalin and gabapentin in spinal stenosis: a systematic review and meta-analysis
av: Telmo Martínez, et al.
Publicerad: (2023-11-01) -
Characterization of hospitalized patients who received naloxone while receiving opioids with or without gabapentinoids
av: Payal H. Desai, PharmD, BCCCP, et al.
Publicerad: (2021-07-01) -
Gabapentin and Pregabalin in chronic neuropathic pain: cost efficacy evaluation
av: Paolo Marchettini, et al.
Publicerad: (2005-05-01)